Optibrium, a provider of software for drug discovery applications, will unveil its latest Stardrop platform at the Molecular Medicine Tri-Conference in San Francisco, California, on 23-25 February.
Stardrop 5 will be previewed in Booth 501 at the Moscone North Convention Centre prior to its official launch at the American Chemical Society (ACS) National Exposition on 27-31 March 2011 in Anaheim, California.
The software includes new features focusing on compound idea generation, enhanced visualisations and mathematical data transformations.
According to the company, quickly identifying the best potential drug molecules is a major challenge; the right balance of multiple, often conflicting, property requirements must be achieved, while the uncertainty in the available data makes effective decision making difficult.
Good compounds are often thrown out in error, or missed by not searching widely enough, meaning wasted productivity, higher costs and a reduced opportunity to discover new drugs.
Stardrop supports pharmaceutical and biotechnology companies to guide their decisions while designing and prioritising molecules for progression in drug discovery.
It integrates all of the available data and explicitly takes into account the underlying uncertainty to provide scientists with intuitive analyses on which to make rational decisions.
According to Optibrium, the new software has an advantage over traditional decision support and modelling platforms as it quickly targets compounds in the regions of chemical space that are most likely to yield successful results.
Its interactive environment brings together a range of drug design features, including ADME QSAR models, P450 metabolism models and automatic predictive model building, along with Stardrop's probabilistic scoring, chemical space and Glowing Molecule visualisations, to improve the efficiency and productivity of the drug discovery process.
A new module stimulates the search for high-quality drugs by generating chemistry ideas, prioritised against the user's property profile requirements.
This expands the chemistry around an initial compound, based on medicinal chemistry transformation rules derived from the literature or in-house chemistry expertise, to generate chemically relevant compounds and fuel a rigorous search for strategies to improve properties.
In addition, extended data visualisation capabilities enable the automatic generation of a range of interactive histograms, graphs, radar plots and chemical spaces.
Combined with new functionality for performing mathematical calculations, Stardrop 5 will help users to manipulate and explore their data without leaving the integrated Stardrop environment.
